SEC Form 4 · accession 0000899243-16-024767
Celator Pharmaceuticals Inc · CPXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred M Powell
Officer — VP and Chief Financial Officer
Period of report
Jul 6, 2016
Accepted (ET)
Jul 7, 2016 · 6:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001327467
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 6, 2016 | M | 71,887 | $3.116 | A | 156,064 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.116 | Jul 6, 2016 | M | 71,887 | D | — | Jun 3, 2023 | Common Stock | 71,887 | 181,113 | D |
Explanation of responses
- F1This option vests as follows: (i) 63,250 options vest on June 3, 2014, (ii) 15,813 options vest on the 3rd day of each of eleven consecutive fiscal quarters beginning on September 3, 2014 and continuing through March 3, 2017 and (iii) 15,807 options vest on June 3, 2017.